Narachi Michael

President and CEO at Orexigen Therapeutics, Inc.

Sold, on record
$3.5M
Dollars the filings state
Form 4 sales
3
Latest Jul 17, 2012
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Orexigen Therapeutics, Inc.Unusual
    Jun 29, 2012 2012

    Sold 225,000 shares at $5.89 ($1.3M)

    Narachi Michael, President and CEO

    Sold 100% of holdings ($1.3M position)0 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Orexigen Therapeutics, Inc.Unusual
    Jul 13, 2012 +14 days

    Sold 150,000 shares at $6.70 ($1M)

    Narachi Michael, President and CEO

    Sold 100% of holdings ($1M position)0 shares leftFiling

  3. 3 Form 4 sale Orexigen Therapeutics, Inc.Unusual
    Jul 17, 2012 +4 days

    Sold 150,000 shares at $7.66 ($1.1M)

    Narachi Michael, President and CEO

    Sold 100% of holdings ($1.1M position)0 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Narachi Michael
Source
Jul 17, 2012Jul 19, 2012Orexigen Therapeutics, Inc.President and CEOForm 4 sale150,000$1.1M100.0%UnusualSEC
Jul 13, 2012Jul 13, 2012Orexigen Therapeutics, Inc.President and CEOForm 4 sale150,000$1M100.0%UnusualSEC
Jun 29, 2012Jun 29, 2012Orexigen Therapeutics, Inc.President and CEOForm 4 sale225,000$1.3M100.0%UnusualSEC